The identification of biomarkers circulating in blood that can be detected using cost-effective and minimally invasive procedures is expected to become a breakthrough innovation for improving the ...
Currently established rapid methods for sterility testing of advanced therapy medicinal products (ATMPs) are mostly based on growth-based processes or the detection of metabolic activities. However, ...